サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1581055

全身性肥満細胞症治療薬の世界市場 (2024～2028年)

Global Systemic Mastocytosis Treatment Market 2024-2028

出版日
発行
TechNavio
ページ情報
英文 209 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
全身性肥満細胞症治療薬の世界市場 (2024～2028年)
出版日: 2024年10月09日
発行: TechNavio
ページ情報: 英文 209 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

全身性肥満細胞症治療薬市場 (2024～2028年)

全身性肥満細胞症治療薬市場は2023年から2028年に1億5,710万米ドル分拡大し、予測期間中に6.2%のCAGRで成長すると予測されます。当レポートでは、全身性肥満細胞症治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25社のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。高齢化人口の増加、血液がんの有病率の増加、医療費の増加が市場を牽引しています。

市場範囲
基準年 2024年
終了年 2028年
予測期間 2024～2028年
成長モメンタム 加速
前年比 (2024年) 5.9%
CAGR 6.2%
増分額 1億5,710万米ドル

当レポートでは、全身性肥満細胞症治療用の診断技術の進歩が、今後数年間の全身性肥満細胞症治療薬市場成長を牽引する主要因の1つであるとしています。また、全身性肥満細胞症治療向け新薬の開発や、全身性肥満細胞症治療用の標的療法の採用拡大も、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio別分析

  • 価格感応度・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模の評価

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 (2023年)
  • 市場の見通し (2023～2028年)

第5章 市場規模実績

  • 全身性肥満細胞症治療薬の世界市場 (2018～2022年)
  • 種類別分析 (2018～2022年)
  • 投与経路別分析 (2018～2022年)
  • 地域別分析 (2018～2022年)
  • 国別分析 (2018～2022年)

第6章 定性分析

  • 世界の全身性肥満細胞症治療薬市場におけるAIの影響

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：種類別

  • 市場セグメンテーション
  • 比較：種類別
  • AK-002：市場規模と予測 (2023～2028年)
  • BLU-285：市場規模と予測 (2023～2028年)
  • ブレンツキシマブベドチン：市場規模と予測 (2023～2028年)
  • クレノラニブベシル酸塩：市場規模と予測 (2023～2028年)
  • その他：市場規模と予測 (2023～2028年)
  • 種類別の市場機会

第9章 市場セグメンテーション：投与経路別

  • 市場セグメンテーション
  • 比較：投与経路別
  • 経口薬：市場規模と予測 (2023～2028年)
  • 注射薬：市場規模と予測 (2023～2028年)
  • 局所薬：市場規模と予測 (2023～2028年)
  • 投与経路別の市場機会

第10章 顧客情勢

  • 顧客情勢の概要

第11章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米：市場規模と予測 (2023～2028年)
  • 欧州：市場規模と予測 (2023～2028年)
  • アジア：市場規模と予測 (2023～2028年)
  • 世界のその他の地域：市場規模と予測 (2023～2028年)
  • 米国：市場規模と予測 (2023～2028年)
  • 中国：市場規模と予測 (2023～2028年)
  • ドイツ：市場規模と予測 (2023～2028年)
  • 英国：市場規模と予測 (2023～2028年)
  • フランス：市場規模と予測 (2023～2028年)
  • スペイン：市場規模と予測 (2023～2028年)
  • カナダ：市場規模と予測 (2023～2028年)
  • 日本：市場規模と予測 (2023～2028年)
  • 韓国：市場規模と予測 (2023～2028年)
  • インド：市場規模と予測 (2023～2028年)
  • 地域別の市場機会

第12章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第13章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第14章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • Blueprint Medicines Corp.
  • Dr Reddys Laboratories Ltd.
  • F. Hoffmann La Roche Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Lupin Ltd.
  • NOVA PHARMA LLC
  • Novartis AG
  • Ono Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Zydus Lifesciences Ltd.

第15章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits11: Overview on criticality of inputs and factors of differentiation
  • Exhibits12: Overview on factors of disruption
  • Exhibits13: Impact of drivers and challenges in 2023 and 2028
  • Exhibits14: Parent Market
  • Exhibits15: Data Table on - Parent Market
  • Exhibits16: Market characteristics analysis
  • Exhibits17: Value Chain Analysis
  • Exhibits18: Offerings of companies included in the market definition
  • Exhibits19: Market segments
  • Exhibits20: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits21: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits22: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits23: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits24: Historic Market Size - Data Table on Global Systemic Mastocytosis Treatment Market 2018 - 2022 ($ million)
  • Exhibits25: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • Exhibits26: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
  • Exhibits27: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits28: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits29: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits30: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits31: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits32: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits33: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits34: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits35: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits36: Chart on Type - Market share 2023-2028 (%)
  • Exhibits37: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits38: Chart on Comparison by Type
  • Exhibits39: Data Table on Comparison by Type
  • Exhibits40: Chart on AK-002 - Market size and forecast 2023-2028 ($ million)
  • Exhibits41: Data Table on AK-002 - Market size and forecast 2023-2028 ($ million)
  • Exhibits42: Chart on AK-002 - Year-over-year growth 2023-2028 (%)
  • Exhibits43: Data Table on AK-002 - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Chart on BLU-285 - Market size and forecast 2023-2028 ($ million)
  • Exhibits45: Data Table on BLU-285 - Market size and forecast 2023-2028 ($ million)
  • Exhibits46: Chart on BLU-285 - Year-over-year growth 2023-2028 (%)
  • Exhibits47: Data Table on BLU-285 - Year-over-year growth 2023-2028 (%)
  • Exhibits48: Chart on Brentuximab vedotin - Market size and forecast 2023-2028 ($ million)
  • Exhibits49: Data Table on Brentuximab vedotin - Market size and forecast 2023-2028 ($ million)
  • Exhibits50: Chart on Brentuximab vedotin - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Brentuximab vedotin - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Chart on Crenolanib besylate - Market size and forecast 2023-2028 ($ million)
  • Exhibits53: Data Table on Crenolanib besylate - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Chart on Crenolanib besylate - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Crenolanib besylate - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits58: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits59: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Market opportunity by Type ($ million)
  • Exhibits61: Data Table on Market opportunity by Type ($ million)
  • Exhibits62: Chart on Route of Administration - Market share 2023-2028 (%)
  • Exhibits63: Data Table on Route of Administration - Market share 2023-2028 (%)
  • Exhibits64: Chart on Comparison by Route of Administration
  • Exhibits65: Data Table on Comparison by Route of Administration
  • Exhibits66: Chart on Oral - Market size and forecast 2023-2028 ($ million)
  • Exhibits67: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
  • Exhibits68: Chart on Oral - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Data Table on Oral - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Chart on Injectables - Market size and forecast 2023-2028 ($ million)
  • Exhibits71: Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
  • Exhibits72: Chart on Injectables - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Chart on Topical - Market size and forecast 2023-2028 ($ million)
  • Exhibits75: Data Table on Topical - Market size and forecast 2023-2028 ($ million)
  • Exhibits76: Chart on Topical - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Data Table on Topical - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Market opportunity by Route of Administration ($ million)
  • Exhibits79: Data Table on Market opportunity by Route of Administration ($ million)
  • Exhibits80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits81: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits82: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits83: Chart on Geographic comparison
  • Exhibits84: Data Table on Geographic comparison
  • Exhibits85: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits98: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits99: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits102: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits103: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits109: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits110: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits111: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits112: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits113: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits114: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits115: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits116: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits117: Chart on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits118: Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits119: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibits120: Data Table on France - Year-over-year growth 2023-2028 (%)
  • Exhibits121: Chart on Spain - Market size and forecast 2023-2028 ($ million)
  • Exhibits122: Data Table on Spain - Market size and forecast 2023-2028 ($ million)
  • Exhibits123: Chart on Spain - Year-over-year growth 2023-2028 (%)
  • Exhibits124: Data Table on Spain - Year-over-year growth 2023-2028 (%)
  • Exhibits125: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits126: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits127: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits128: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits129: Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits130: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Exhibits131: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits132: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits133: Chart on South Korea - Market size and forecast 2023-2028 ($ million)
  • Exhibits134: Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
  • Exhibits135: Chart on South Korea - Year-over-year growth 2023-2028 (%)
  • Exhibits136: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
  • Exhibits137: Chart on India - Market size and forecast 2023-2028 ($ million)
  • Exhibits138: Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Exhibits139: Chart on India - Year-over-year growth 2023-2028 (%)
  • Exhibits140: Data Table on India - Year-over-year growth 2023-2028 (%)
  • Exhibits141: Market opportunity By Geographical Landscape ($ million)
  • Exhibits142: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits143: Impact of drivers and challenges in 2023 and 2028
  • Exhibits144: Overview on criticality of inputs and factors of differentiation
  • Exhibits145: Overview on factors of disruption
  • Exhibits146: Impact of key risks on business
  • Exhibits147: Companies covered
  • Exhibits148: Company ranking index
  • Exhibits149: Matrix on companies position and classification
  • Exhibits150: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
  • Exhibits151: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
  • Exhibits152: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
  • Exhibits153: SWOT
  • Exhibits154: Blueprint Medicines Corp. - Overview
  • Exhibits155: Blueprint Medicines Corp. - Product / Service
  • Exhibits156: Blueprint Medicines Corp. - Key news
  • Exhibits157: Blueprint Medicines Corp. - Key offerings
  • Exhibits158: SWOT
  • Exhibits159: Dr Reddys Laboratories Ltd. - Overview
  • Exhibits160: Dr Reddys Laboratories Ltd. - Business segments
  • Exhibits161: Dr Reddys Laboratories Ltd. - Key news
  • Exhibits162: Dr Reddys Laboratories Ltd. - Key offerings
  • Exhibits163: Dr Reddys Laboratories Ltd. - Segment focus
  • Exhibits164: SWOT
  • Exhibits165: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits166: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits167: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits168: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits169: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits170: SWOT
  • Exhibits171: Glenmark Pharmaceuticals Ltd. - Overview
  • Exhibits172: Glenmark Pharmaceuticals Ltd. - Product / Service
  • Exhibits173: Glenmark Pharmaceuticals Ltd. - Key offerings
  • Exhibits174: SWOT
  • Exhibits175: Intas Pharmaceuticals Ltd. - Overview
  • Exhibits176: Intas Pharmaceuticals Ltd. - Product / Service
  • Exhibits177: Intas Pharmaceuticals Ltd. - Key offerings
  • Exhibits178: SWOT
  • Exhibits179: Lupin Ltd. - Overview
  • Exhibits180: Lupin Ltd. - Business segments
  • Exhibits181: Lupin Ltd. - Key news
  • Exhibits182: Lupin Ltd. - Key offerings
  • Exhibits183: Lupin Ltd. - Segment focus
  • Exhibits184: SWOT
  • Exhibits185: NOVA PHARMA LLC - Overview
  • Exhibits186: NOVA PHARMA LLC - Product / Service
  • Exhibits187: NOVA PHARMA LLC - Key offerings
  • Exhibits188: SWOT
  • Exhibits189: Novartis AG - Overview
  • Exhibits190: Novartis AG - Business segments
  • Exhibits191: Novartis AG - Key news
  • Exhibits192: Novartis AG - Key offerings
  • Exhibits193: Novartis AG - Segment focus
  • Exhibits194: SWOT
  • Exhibits195: Ono Pharmaceutical Co. Ltd. - Overview
  • Exhibits196: Ono Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits197: Ono Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits198: SWOT
  • Exhibits199: Pfizer Inc. - Overview
  • Exhibits200: Pfizer Inc. - Product / Service
  • Exhibits201: Pfizer Inc. - Key news
  • Exhibits202: Pfizer Inc. - Key offerings
  • Exhibits203: SWOT
  • Exhibits204: Sanofi SA - Overview
  • Exhibits205: Sanofi SA - Business segments
  • Exhibits206: Sanofi SA - Key news
  • Exhibits207: Sanofi SA - Key offerings
  • Exhibits208: Sanofi SA - Segment focus
  • Exhibits209: SWOT
  • Exhibits210: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibits211: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibits212: Sun Pharmaceutical Industries Ltd. - Key news
  • Exhibits213: Sun Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits214: SWOT
  • Exhibits215: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibits216: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits217: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibits218: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits219: SWOT
  • Exhibits220: Zydus Lifesciences Ltd. - Overview
  • Exhibits221: Zydus Lifesciences Ltd. - Business segments
  • Exhibits222: Zydus Lifesciences Ltd. - Key news
  • Exhibits223: Zydus Lifesciences Ltd. - Key offerings
  • Exhibits224: Zydus Lifesciences Ltd. - Segment focus
  • Exhibits225: SWOT
  • Exhibits226: Inclusions checklist
  • Exhibits227: Exclusions checklist
  • Exhibits228: Currency conversion rates for US$
  • Exhibits229: Research methodology
  • Exhibits230: Information sources
  • Exhibits231: Data validation
  • Exhibits232: Validation techniques employed for market sizing
  • Exhibits233: Data synthesis
  • Exhibits234: 360 degree market analysis
  • Exhibits235: List of abbreviations
目次
Product Code: IRTNTR80230

Systemic Mastocytosis Treatment Market 2024-2028

The systemic mastocytosis treatment market is forecasted to grow by USD 157.1 million during 2023-2028, accelerating at a CAGR of 6.2% during the forecast period. The report on the systemic mastocytosis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth of aging population, increasing prevalence of blood cancer, and growing healthcare expenditure.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20245.9%
CAGR6.2%
Incremental Value$157.1 mn

Technavio's systemic mastocytosis treatment market is segmented as below:

By Type

    • AK-002
    • BLU-285
    • Brentuximab vedotin
    • Crenolanib besylate
    • Others

By Route Of Administration

    • Oral
    • Injectables
    • Topical

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the advancements in diagnostic technologies for systemic mastocytosis treatment as one of the prime reasons driving the systemic mastocytosis treatment market growth during the next few years. Also, development of new drugs for systemic mastocytosis treatment and growing adoption of targeted therapies for systemic mastocytosis treatment will lead to sizable demand in the market.

The report on the systemic mastocytosis treatment market covers the following areas:

    • Systemic Mastocytosis Treatment Market sizing
    • Systemic Mastocytosis Treatment Market forecast
    • Systemic Mastocytosis Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading systemic mastocytosis treatment market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, AB Science SA, AdvaCare Pharma, BDR Pharmaceuticals Internationals Pvt. Ltd, Blueprint Medicines Corp., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., NOVA PHARMA LLC, Novartis AG, Ono Pharmaceutical Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Zydus Lifesciences Ltd.. Also, the systemic mastocytosis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Market Segmentation by Route of Administration
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value Chain Analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2023
  • 4.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

  • 5.1 Global Systemic Mastocytosis Treatment Market 2018 - 2022
    • Historic Market Size - Data Table on Global Systemic Mastocytosis Treatment Market 2018 - 2022 ($ million)
  • 5.2 Type segment analysis 2018 - 2022
    • Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • 5.3 Route of Administration segment analysis 2018 - 2022
    • Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
  • 5.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 5.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on the Global Systemic Mastocytosis Treatment Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Type

  • 8.1 Market segments
    • Chart on Type - Market share 2023-2028 (%)
    • Data Table on Type - Market share 2023-2028 (%)
  • 8.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 8.3 AK-002 - Market size and forecast 2023-2028
    • Chart on AK-002 - Market size and forecast 2023-2028 ($ million)
    • Data Table on AK-002 - Market size and forecast 2023-2028 ($ million)
    • Chart on AK-002 - Year-over-year growth 2023-2028 (%)
    • Data Table on AK-002 - Year-over-year growth 2023-2028 (%)
  • 8.4 BLU-285 - Market size and forecast 2023-2028
    • Chart on BLU-285 - Market size and forecast 2023-2028 ($ million)
    • Data Table on BLU-285 - Market size and forecast 2023-2028 ($ million)
    • Chart on BLU-285 - Year-over-year growth 2023-2028 (%)
    • Data Table on BLU-285 - Year-over-year growth 2023-2028 (%)
  • 8.5 Brentuximab vedotin - Market size and forecast 2023-2028
    • Chart on Brentuximab vedotin - Market size and forecast 2023-2028 ($ million)
    • Data Table on Brentuximab vedotin - Market size and forecast 2023-2028 ($ million)
    • Chart on Brentuximab vedotin - Year-over-year growth 2023-2028 (%)
    • Data Table on Brentuximab vedotin - Year-over-year growth 2023-2028 (%)
  • 8.6 Crenolanib besylate - Market size and forecast 2023-2028
    • Chart on Crenolanib besylate - Market size and forecast 2023-2028 ($ million)
    • Data Table on Crenolanib besylate - Market size and forecast 2023-2028 ($ million)
    • Chart on Crenolanib besylate - Year-over-year growth 2023-2028 (%)
    • Data Table on Crenolanib besylate - Year-over-year growth 2023-2028 (%)
  • 8.7 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ million)
    • Data Table on Others - Market size and forecast 2023-2028 ($ million)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 8.8 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Route of Administration

  • 9.1 Market segments
    • Chart on Route of Administration - Market share 2023-2028 (%)
    • Data Table on Route of Administration - Market share 2023-2028 (%)
  • 9.2 Comparison by Route of Administration
    • Chart on Comparison by Route of Administration
    • Data Table on Comparison by Route of Administration
  • 9.3 Oral - Market size and forecast 2023-2028
    • Chart on Oral - Market size and forecast 2023-2028 ($ million)
    • Data Table on Oral - Market size and forecast 2023-2028 ($ million)
    • Chart on Oral - Year-over-year growth 2023-2028 (%)
    • Data Table on Oral - Year-over-year growth 2023-2028 (%)
  • 9.4 Injectables - Market size and forecast 2023-2028
    • Chart on Injectables - Market size and forecast 2023-2028 ($ million)
    • Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
    • Chart on Injectables - Year-over-year growth 2023-2028 (%)
    • Data Table on Injectables - Year-over-year growth 2023-2028 (%)
  • 9.5 Topical - Market size and forecast 2023-2028
    • Chart on Topical - Market size and forecast 2023-2028 ($ million)
    • Data Table on Topical - Market size and forecast 2023-2028 ($ million)
    • Chart on Topical - Year-over-year growth 2023-2028 (%)
    • Data Table on Topical - Year-over-year growth 2023-2028 (%)
  • 9.6 Market opportunity by Route of Administration
    • Market opportunity by Route of Administration ($ million)
    • Data Table on Market opportunity by Route of Administration ($ million)

10 Customer Landscape

  • 10.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

  • 11.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 11.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 11.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 11.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 11.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 11.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 11.8 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 11.9 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 11.10 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 11.11 France - Market size and forecast 2023-2028
    • Chart on France - Market size and forecast 2023-2028 ($ million)
    • Data Table on France - Market size and forecast 2023-2028 ($ million)
    • Chart on France - Year-over-year growth 2023-2028 (%)
    • Data Table on France - Year-over-year growth 2023-2028 (%)
  • 11.12 Spain - Market size and forecast 2023-2028
    • Chart on Spain - Market size and forecast 2023-2028 ($ million)
    • Data Table on Spain - Market size and forecast 2023-2028 ($ million)
    • Chart on Spain - Year-over-year growth 2023-2028 (%)
    • Data Table on Spain - Year-over-year growth 2023-2028 (%)
  • 11.13 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ million)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 11.14 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ million)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 11.15 South Korea - Market size and forecast 2023-2028
    • Chart on South Korea - Market size and forecast 2023-2028 ($ million)
    • Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
    • Chart on South Korea - Year-over-year growth 2023-2028 (%)
    • Data Table on South Korea - Year-over-year growth 2023-2028 (%)
  • 11.16 India - Market size and forecast 2023-2028
    • Chart on India - Market size and forecast 2023-2028 ($ million)
    • Data Table on India - Market size and forecast 2023-2028 ($ million)
    • Chart on India - Year-over-year growth 2023-2028 (%)
    • Data Table on India - Year-over-year growth 2023-2028 (%)
  • 11.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

  • 12.1 Market drivers
  • 12.2 Market challenges
  • 12.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 12.4 Market opportunities/restraints

13 Competitive Landscape

  • 13.1 Overview
  • 13.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 13.3 Landscape disruption
    • Overview on factors of disruption
  • 13.4 Industry risks
    • Impact of key risks on business

14 Competitive Analysis

  • 14.1 Companies profiled
    • Companies covered
  • 14.2 Company ranking index
    • Company ranking index
  • 14.3 Market positioning of companies
    • Matrix on companies position and classification
  • 14.4 A. Menarini Industrie Farmaceutiche Riunite Srl
    • A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
    • A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
    • A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
    • SWOT
  • 14.5 Blueprint Medicines Corp.
    • Blueprint Medicines Corp. - Overview
    • Blueprint Medicines Corp. - Product / Service
    • Blueprint Medicines Corp. - Key news
    • Blueprint Medicines Corp. - Key offerings
    • SWOT
  • 14.6 Dr Reddys Laboratories Ltd.
    • Dr Reddys Laboratories Ltd. - Overview
    • Dr Reddys Laboratories Ltd. - Business segments
    • Dr Reddys Laboratories Ltd. - Key news
    • Dr Reddys Laboratories Ltd. - Key offerings
    • Dr Reddys Laboratories Ltd. - Segment focus
    • SWOT
  • 14.7 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 14.8 Glenmark Pharmaceuticals Ltd.
    • Glenmark Pharmaceuticals Ltd. - Overview
    • Glenmark Pharmaceuticals Ltd. - Product / Service
    • Glenmark Pharmaceuticals Ltd. - Key offerings
    • SWOT
  • 14.9 Intas Pharmaceuticals Ltd.
    • Intas Pharmaceuticals Ltd. - Overview
    • Intas Pharmaceuticals Ltd. - Product / Service
    • Intas Pharmaceuticals Ltd. - Key offerings
    • SWOT
  • 14.10 Lupin Ltd.
    • Lupin Ltd. - Overview
    • Lupin Ltd. - Business segments
    • Lupin Ltd. - Key news
    • Lupin Ltd. - Key offerings
    • Lupin Ltd. - Segment focus
    • SWOT
  • 14.11 NOVA PHARMA LLC
    • NOVA PHARMA LLC - Overview
    • NOVA PHARMA LLC - Product / Service
    • NOVA PHARMA LLC - Key offerings
    • SWOT
  • 14.12 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT
  • 14.13 Ono Pharmaceutical Co. Ltd.
    • Ono Pharmaceutical Co. Ltd. - Overview
    • Ono Pharmaceutical Co. Ltd. - Product / Service
    • Ono Pharmaceutical Co. Ltd. - Key offerings
    • SWOT
  • 14.14 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 14.15 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
    • SWOT
  • 14.16 Sun Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd. - Overview
    • Sun Pharmaceutical Industries Ltd. - Product / Service
    • Sun Pharmaceutical Industries Ltd. - Key news
    • Sun Pharmaceutical Industries Ltd. - Key offerings
    • SWOT
  • 14.17 Takeda Pharmaceutical Co. Ltd.
    • Takeda Pharmaceutical Co. Ltd. - Overview
    • Takeda Pharmaceutical Co. Ltd. - Product / Service
    • Takeda Pharmaceutical Co. Ltd. - Key news
    • Takeda Pharmaceutical Co. Ltd. - Key offerings
    • SWOT
  • 14.18 Zydus Lifesciences Ltd.
    • Zydus Lifesciences Ltd. - Overview
    • Zydus Lifesciences Ltd. - Business segments
    • Zydus Lifesciences Ltd. - Key news
    • Zydus Lifesciences Ltd. - Key offerings
    • Zydus Lifesciences Ltd. - Segment focus
    • SWOT

15 Appendix

  • 15.1 Scope of the report
  • 15.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 15.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 15.4 Research methodology
    • Research methodology
  • 15.5 Data procurement
    • Information sources
  • 15.6 Data validation
    • Data validation
  • 15.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 15.8 Data synthesis
    • Data synthesis
  • 15.9 360 degree market analysis
    • 360 degree market analysis
  • 15.10 List of abbreviations
    • List of abbreviations